GIBSON, SCOTT R.,MOBERG, SHELDON B.,TAHA, BASEL HASAN,BOYAVAL, MARGAUX FRANCES,DESTEFANO, MARK A.,LAURENCE, LAWTON,LOVE, JOHN C.,HANSON, IAN B.,BENTE, PAUL F., IV,CLEMENTE, MATTHEW J.,UBACH, ANTONIO,R
申请号：
CA3020337
公开号：
CA3020337A1
申请日:
2017.04.07
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor (G-CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device includes a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector defines a sterile fluid flowpath between the container and the insertion mechanism. A cannula initially disposed about the needle is included.
